Skip to content

Awamori raises HDL, reduces the onset of heart disease and cerebrovascular accidents, improves peripheral neuromuscular disorders and dementia, enhances the activities of daily living, and prevents the onset of infections increasing the longevity of the residents of Okinawa

Awamori luchuensis increases the longevity - the effect of Awamori luchuensis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000049193
Enrollment
5783
Registered
2022-10-12
Start date
2020-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperlipidemia, heart disease, cerebrovascular accidents, peripheral neuromuscular disorders, dementia, infections, aged disease

Interventions

None listed

Sponsors

Daido Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 A total of 5109 outpatients, age range, 3592 years, who visited the hospital for health checkup were included in the study. 2 A total of 674 inpatients, mean age, 88 years, age range, 81 98 years, were evaluated.

Exclusion criteria

Exclusion criteria: 1 among them, 825 people who did not drink alcohol were excluded. Of the remaining 4284 outpatients who had a drinking habit, 1430 were excluded due to various factors. Of the remaining 2854 outpatients who were within the examination standard value, 755 people who exercised regularly were excluded. Subsequently, 1822 out of the remaining 2099 outpatients who had a drinking habit and did not exercise regularly were excluded because they consumed other alcoholic drinks such as wine, sake, beer, and whiskey. Finally, 277 outpatients who consumed only Awamori were included in this study, which was conducted over a period of 1 year from January to December 2019. 2 Among them, 31 were excluded because they did not belong to the Okinawa prefecture. Of the 643 remaining patients, 374 were excluded because they presented with the following conditions, unknown drinking history, unknown identity, untraceable duration, disagreement, alcoholism, thyroid disease, fractures, bedridden for 50% over of the day, inability to consume food orally, and inability to speak. Finally, the clinical findings, laboratory findings, and extent of rehabilitation were compared between 134 patients who consumed Awamori, less 1 gou almost every day for more than 20 years until admission, and 106 patients who did not Awamori, which was conducted over a period of 3 year from January to December 2019.

Design outcomes

Primary

MeasureTime frame
The levels of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol and triglycerides were measured in 5161 outpatients who consumed Awamori. Additionally, heart disease, brain disease, virus infections, tumor morbidity, neuropathy improvement rate, and survival rate after rehabilitation were measured in 641 inpatients aged 80 over years who consumed Awamori for 20 years.

Countries

Japan

Contacts

Public ContactKenji Gonda

Daido Central Hospital Surgery

gondake@fmu.ac.jp098-869-0005

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026